Prevalence of use and acute toxicity associated with the use of NBOMe drugs

References

• UNODC. The challenge of the New Psychoactive Substances. Available at: http://wwwunodcorg/documents/scientific/NPS_2013_SMARTpdf 2013. (last accessed 1st October 2014)
   Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2014. Available at: http://wwwemcddaeuropaeu/edr2014. (last accessed 1st October 2014)
   Google Scholar
• EMCDDA. Risk Assessment Report of a new psychoactive substance: 2-(4-iodo-2,4-dimethoxyphenyl)-N-(2-methoxybenzy)ethanamine (25I-NBOMe). Available at: http://wwwemcddaeuropaeu/publications/risk-assessment/25I-NBOMe. (last accessed 1st October 2014)
   Google Scholar
• Abstracts of the 2010 International Congress of the European Association of Poisons Centres and Clinical Toxicologists, 11-14 May 2010, Bordeaux, France. Clin Toxicol (Phila) 2010; 48:240–318.
   Google Scholar
• Abstracts of the 2011 International Congress of the European Association of Poisons Centres and Clinical Toxicologists, 24–27 May 2011, Dubrovnik, Croatia. Clin Toxicol (Phila) 2011; 49:197–269.
   Google Scholar
• Abstracts of the 2012 International Congress of the European Association of Poisons Centres and Clinical Toxicologists, 25 May– 1 June 2012, London, UK. Clin Toxicol (Phila) 2012; 50:273–366.
   Google Scholar
• XXXIII International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) 28–31 May 2013, Copenhagen, Denmark. Clin Toxicol (Phila) 2013; 51:252–378.
   Google Scholar
• XXXIV International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) 27–30 May 2014, Brussels, Belgium. Clin Toxicol (Phila) 2014; 52:295–443.
   Google Scholar
• Abstracts of the 2010 North American Congress of Clinical Toxicology Annual Meeting, October 7–12, 2010, Denver, CO, USA. Clin Toxicol (Phila) 2010; 48:604–667.
   Google Scholar
• Abstracts of the 2011 North American Congress of Clinical Toxicology Annual Meeting, September 21–26, Washington, DC, USA. Clin Toxicol (Phila) 2011; 49:515–627.
   Google Scholar
• Annual Meeting of the North American Congress of Clinical Toxicology (NACCT) October 1–6, 2012 Las Vegas, NV, USA. Clin Toxicol (Phila) 2012;50:574–720.
   Google Scholar
• Annual Meeting of the North American Congress of Clinical Toxicology (NACCT). Clin Toxicol (Phila) 2013; 51:575–724.
   Google Scholar
• European Information System and Database on New Drugs (EDND). Available at: https://ednd-cmaemcddaeuropaeu/ (last accessed 1st October 2014)
   Google Scholar
• Uchiyama N, Shimokawa Y, Matsuda S, Kawamura M, Kikura-Hanajiri R, Goda Y. Two new synthetic cannabinoids, AM-2201 benzimidazole analog (FUBIMINA) and (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone (MEPIRAPIM), and three phenethylamine derivatives, 25H-NBOMe 3,4,5-trimethoxybenzyl analog, 25B-NBOMe, and 2C-N-NBOMe, identified in illegal products. Forensic Toxicol 2014; 32:105–115.
   Web of Science ®Google Scholar
• DEA. U.S. Drug Enforcement Administration, Office of Diversion Control: National Forensic Laboratory Information System: Midyear Report2013. Springfield, VA: USDrug Enforcement Administration. 2014. (last accessed 1st October 2014)
   Google Scholar
• UNODC-EWA: 25I-NBOMe is the most reported substance in 2014. Available at: https://www.unodc.org/LSS/Announcement/Details/f6acf081-dd51-4d23-9c66-d01eeef5cbf9 (last accessed 1st October 2014).
   Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction. Early Warning System. Available at: http://wwwemcddaeuropaeu/themes/new-drugs/early-warning. (last accessed 1st October 2014).
   Google Scholar
• Lawn W, Barratt M, Williams M, Horne A, Winstock A. The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sample. J Psychopharmacol 2014; 28:780–788.
   PubMed Web of Science ®Google Scholar
• Lovett CJ, Measham F, Dargan PI, Wood DM. Awareness and use of the NBOMe novel psychoactive substances is lower than those of mephedrone in a high drug using population. Clin Toxicol (Phila) 2014; 52:361.
   Web of Science ®Google Scholar
• Moore K, Dargan PI, Wood DM, Measham F. Do novel psychoactive substances displace established club drugs, supplement them or act as drugs of initiation? The relationship between mephedrone, ecstasy and cocaine. Eur Addict Res 2013; 19:276–282.
   PubMed Web of Science ®Google Scholar
• Wood DM, Hunter L, Measham F, Dargan PI. Limited use of novel psychoactive substances in South London nightclubs. QJM 2012; 105:959–964.
   PubMed Web of Science ®Google Scholar
• Wood DM, Measham F, Dargan PI.‘Our favourite drug’: prevalence of use and preference for mephedrone in the London night time economy one year afer control. J Subs Use 2012; 68:853–856.
   Google Scholar
• Earth and Fire Erowid. Spotlight on NBOMes: Potent Psychedelic Issues. Erowid Extracts. 2013; 24:2–5.
   Google Scholar
• Tang MH, Ching CK, Tsui MS, Chu FK, Mak TW. Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe. Clin Toxicol (Phila) 2014; 52:561–565.
   PubMed Web of Science ®Google Scholar
• Poklis JL, Nanco CR, Troendle MM, Wolf CE, Poklis A. Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication. Drug Test Anal 2014; 6:764–769.
   PubMed Web of Science ®Google Scholar
• Grautoff S, Kahler J. [Near fatal intoxication with the novel psychoactive substance 25C-NBOMe]. Med Klin Intensivmed Notfallmed 2014; 109:271–275.
   Web of Science ®Google Scholar
• Nefcy A, Wilson J, Smith MP, Maso K, Bora K. Which reality is this? A novel PCP analog combined with 2C-NBOMe causes a dissociative serotonin syndrome. Clin Toxicol (Phila) 2013; 51:665.
   Web of Science ®Google Scholar
• Armenian P, Gerona RR. The electric Kool-Aid NBOMe test: LC-TOF/MS confirmed 2C-C-NBOMe (25C) intoxication at Burning Man. Am J Emerg Med. Epub ahead of print 26 Apr 2014 [DOI: 10.1016/j.ajem.2014.04.047]
   PubMed Web of Science ®Google Scholar
• Armenian P, Gerona RR. The electric koolaid NBOMe test: LC-TOF/MS confirmed 2C-C-NBOMe (25C) intoxication at Burning Man. Clin Toxicol (Phila) 2014; 52:363–364.
   Web of Science ®Google Scholar
• Stellpflug SJ, Kealey SE, Hegarty CB, Janis GC. 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing. J Med Toxicol 2014; 10:45–50.
   PubMedGoogle Scholar
• Hill SL, Doris T, Gurung S, Katebe S, Lomas A, Dunn M, et al. Severe clinical toxicity associated with analytically confirmed recreational use of 25I-NBOMe: case series. Clin Toxicol (Phila) 2013; 51:487–492.
   PubMed Web of Science ®Google Scholar
• Rose SR, Poklis JL, Poklis A. A case of 25I-NBOMe (25-I) intoxication: a new potent 5-HT2A agonist designer drug. Clin Toxicol (Phila) 2013; 51:174–177.
   PubMed Web of Science ®Google Scholar
• Rose SR, Cumpston KL, Stromberg PE, Wills BK. Severe poisoning following self-reported use of 25-I, a nove substituted amphetamine. Clin Toxicol (Phila) 2012; 50:707–708.
   Web of Science ®Google Scholar
• Poklis JL, Charles J, Wolf CE, Poklis A. High-performance liquid chromatography tandem mass spectrometry method for the determination of 2CC-NBOMe and 25I-NBOMe in human serum. Biomed Chromatogr 2013; 27:1794–1800.
   PubMed Web of Science ®Google Scholar
• Kelly A, Eisnga B, Riley B, Judge B. Case series of 25I-NBOMe exposures with laboratory confirmation. Clin Toxicol (Phila) 2012; 50:702.
   Web of Science ®Google Scholar
• Forrester MB. NBOMe designer drug exposures reported to Texas poisons centers. J Addict Dis 2014; 33:196–201.
   PubMed Web of Science ®Google Scholar
• Ralston N, Davies L. Teen jumps to his death after $1.50 drug hit 2013. Available from: http://www.smh.com.au/nsw/teen-jumps-to-his-death-after-150-drug-hit-20130606-2nrpe.html#ixzz35BP7Ymmx. (last accessed 1st October 2014).
   Google Scholar
• Caldicott DG, Bright SJ, Barratt MJ. NBOMe – a very different kettle of fish. Med J Aust 2013; 199:322–323.
   PubMed Web of Science ®Google Scholar
• Poklis JL, Devers KG, Arbefeville EF, Pearson JM, Houston E, Poklis A. Postmortem detection of 25I-NBOMe [2-(4-iodo-2, 5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death. Forensic Sci Int 2014; 234:e14–20.
   PubMed Web of Science ®Google Scholar
• Walterscheid JP, Phillips GT, Lopez AE, Gonsoulin ML, Chen HH, Sanchez LA. Pathological findings in 2 cases of fatal 25I-NBOMe toxicity. Am J Forensic Med Pathol 2014; 35:20–25.
   PubMed Web of Science ®Google Scholar